Roomi MW, Roomi NW, Ivanov V, Netke SP, Niedzwiecki A, Rath M

Presented at: 
International Research Conference on Food, Nutrition and Cancer, Washington D.C., July 17-18, 2003

Published in: 
International Research Conference on Food, Nutrition and Cancer Proceedings: Colorectal Cancer, Abstract #8.

Comment

Colon cancer, the second leading cause of cancer death in the United States, results in 55,000 deaths per year, mainly secondary to metastasis. In this study, NS was found to significantly inhibit the metastatic parameters of MMP-9 expression and Matrigel invasion without alteration in cell morphology. These results suggest that Nutrient Synergy not only has great anti-metastatic potential as a therapeutic agent for colon cancer, but also is safe to use.